← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
SC 13GMS INITIALFeb 9, 2024SC 13GSCHEDULE 13GAug 18, 2023SC 13GSC 13GFeb 8, 2022SC 13GSCHEDULE 13GFeb 16, 2021SC 13GSCHEDULE 13GFeb 10, 2021SC 13GSC 13GJun 1, 2020SC 13GSC 13GFeb 10, 2020SC 13GSC 13GFeb 11, 2019SC 13GNOVAVAX INCFeb 8, 2017SC 13GSC 13GFeb 11, 2016SC 13GSCHEDULE 13GFeb 5, 2016SC 13GNVAX AS OF 12/31/2014Feb 12, 2015SC 13GSC 13GJan 30, 2013
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance